Sarah Hymowitz, PhD
InvestorPartner at The Column Group
About
Sarah Hymowitz combines a UCSF PhD in biophysics with 22 years at Genentech—including VP of Protein Sciences—oversight of 35+ large-molecule clinical candidates and a leading role in discovering Venclexta.
Invests in
BiotechHealthtech
Colleagues at The Column Group
Aadit Shah
Principal at The Column Group
Arnav Mehta, MD, PhD
Venture Partner at The Column Group
Carla Daniel
Partner at The Column Group
Craig Parker
Venture Partner at The Column Group
Hui Tian
Partner at The Column Group
Hui Tian, PhD
Partner at The Column Group
James Evangelista
Partner and CFO at The Column Group
JeenJoo Kang
Venture Partner at The Column Group
Frequently asked questions
- Who is Sarah Hymowitz, PhD?
- Sarah Hymowitz combines a UCSF PhD in biophysics with 22 years at Genentech—including VP of Protein Sciences—oversight of 35+ large-molecule clinical candidates and a leading role in discovering Venclexta.
- Where does Sarah Hymowitz, PhD work?
- Sarah Hymowitz, PhD is Partner at The Column Group.
- What does Sarah Hymowitz, PhD invest in?
- Sarah Hymowitz, PhD invests in Biotech, Healthtech.





